Evonik (0QDS) Share Forecast & Price Target

Compare

5 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0QDS Analyst Ratings

Hold

1 Buy

7 Hold

3 Sell

Based on 11 analysts giving stock ratings to

Evonik

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0QDS Stock 12 Month Forecast

Average Price Target

€14.41

▲(9.17% Upside)

Based on 11 Wall Street analysts offering 12 month price targets for Evonik in the last 3 months. The average price target is €14.41 with a high forecast of €20.40 and a low forecast of €11.60. The average price target represents a 9.17% change from the last price of €13.20.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"€10","21":"€21","12.75":"€12.75","15.5":"€15.5","18.25":"€18.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":20.4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€20.40</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14.41,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€14.41</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€11.60</span>\n  </div></div>","useHTML":true}}],"tickPositions":[10,12.75,15.5,18.25,21],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.18,13.735384615384614,14.29076923076923,14.846153846153845,15.401538461538461,15.956923076923076,16.51230769230769,17.067692307692305,17.623076923076923,18.178461538461537,18.73384615384615,19.28923076923077,19.84461538461538,{"y":20.4,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.18,13.274615384615384,13.36923076923077,13.463846153846154,13.558461538461538,13.653076923076924,13.747692307692308,13.842307692307692,13.936923076923076,14.031538461538462,14.126153846153846,14.22076923076923,14.315384615384616,{"y":14.41,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.18,13.058461538461538,12.936923076923076,12.815384615384614,12.693846153846154,12.572307692307692,12.45076923076923,12.329230769230769,12.207692307692307,12.086153846153845,11.964615384615385,11.843076923076923,11.721538461538461,{"y":11.6,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":16.31,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.8,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.17,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.95,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.82,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.48,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.88,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.19,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.52,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.41,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.88,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.69,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.18,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€20.40

Average Price Target€14.41

Lowest Price Target€11.60

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Martin Roediger

Kepler Capital

€12.6→€11.9

Sell

-9.85%

Downside

Reiterated

12/17/25

Geoff Haire

UBS

€14→€13

Hold

-1.52%

Downside

Reiterated

12/16/25

UBS Keeps Their Hold Rating on Evonik (0QDS)

Sebastian Satz

Citi

€18→€17

Buy

28.79%

Upside

Reiterated

12/11/25

Evonik price target lowered to EUR 17 from EUR 18 at CitiEvonik price target lowered to EUR 17 from EUR 18 at Citi

Chetan Udeshi

J.P. Morgan

€20→€14

Hold

6.06%

Upside

Downgraded

11/28/25

J.P. Morgan downgrades Evonik (0QDS) to a Hold

Virginie Boucher-Ferte

Deutsche Bank

€16→€13

Hold

-1.52%

Downside

Reiterated

11/24/25

Deutsche Bank Remains a Hold on Evonik (0QDS)

Gaurav Jain

Barclays

€25→€16

Hold

21.21%

Upside

Downgraded

11/12/25

Barclays downgrades Evonik (0QDS) to a Hold

Georgina Fraser CFA

Goldman Sachs

€16.5→€11.6

Sell

-12.12%

Downside

Downgraded

11/11/25

Goldman Sachs Remains a Sell on Evonik (0QDS)

Chris Counihan

Jefferies

€15.1→€12.2

Sell

-7.58%

Downside

Downgraded

11/11/25

Jefferies downgrades Evonik (0QDS) to a Sell

Peter Spengler

DZ BANK AG

Hold

―

Reiterated

11/05/25

Evonik (0QDS) Receives a Hold from DZ BANK AG

Oliver Schwarz

Warburg Research

€20.4

Hold

54.55%

Upside

Reiterated

11/04/25

Warburg Research Sticks to Their Hold Rating for Evonik (0QDS)

Sebastian Bray

Berenberg Bank

€16→€15

Hold

13.64%

Upside

Reiterated

10/20/25

Berenberg Bank Remains a Hold on Evonik (0QDS)

Thomas Wrigglesworth

Morgan Stanley

€17.8

Sell

34.85%

Upside

Reiterated

09/25/25

Morgan Stanley Keeps Their Sell Rating on Evonik (0QDS)

David Symonds

Exane BNP Paribas

€22

Buy

66.67%

Upside

Initiated

07/16/25

Exane BNP Paribas Initiates a Buy Rating on Evonik (0QDS)

Andreas Heine

Stifel Nicolaus

€23

Buy

74.24%

Upside

Reiterated

03/18/25

Evonik's Strong Growth Potential and Resilience: A Buy Recommendation by Andreas Heine

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Martin Roediger

Kepler Capital

€12.6→€11.9

Sell

-9.85%

Downside

Reiterated

12/17/25

Geoff Haire

UBS

€14→€13

Hold

-1.52%

Downside

Reiterated

12/16/25

UBS Keeps Their Hold Rating on Evonik (0QDS)

Sebastian Satz

Citi

€18→€17

Buy

28.79%

Upside

Reiterated

12/11/25

Evonik price target lowered to EUR 17 from EUR 18 at CitiEvonik price target lowered to EUR 17 from EUR 18 at Citi

Chetan Udeshi

J.P. Morgan

€20→€14

Hold

6.06%

Upside

Downgraded

11/28/25

J.P. Morgan downgrades Evonik (0QDS) to a Hold

Virginie Boucher-Ferte

Deutsche Bank

€16→€13

Hold

-1.52%

Downside

Reiterated

11/24/25

Deutsche Bank Remains a Hold on Evonik (0QDS)

Gaurav Jain

Barclays

€25→€16

Hold

21.21%

Upside

Downgraded

11/12/25

Barclays downgrades Evonik (0QDS) to a Hold

Georgina Fraser CFA

Goldman Sachs

€16.5→€11.6

Sell

-12.12%

Downside

Downgraded

11/11/25

Goldman Sachs Remains a Sell on Evonik (0QDS)

Chris Counihan

Jefferies

€15.1→€12.2

Sell

-7.58%

Downside

Downgraded

11/11/25

Jefferies downgrades Evonik (0QDS) to a Sell

Peter Spengler

DZ BANK AG

Hold

―

Reiterated

11/05/25

Evonik (0QDS) Receives a Hold from DZ BANK AG

Oliver Schwarz

Warburg Research

€20.4

Hold

54.55%

Upside

Reiterated

11/04/25

Warburg Research Sticks to Their Hold Rating for Evonik (0QDS)

Sebastian Bray

Berenberg Bank

€16→€15

Hold

13.64%

Upside

Reiterated

10/20/25

Berenberg Bank Remains a Hold on Evonik (0QDS)

Thomas Wrigglesworth

Morgan Stanley

€17.8

Sell

34.85%

Upside

Reiterated

09/25/25

Morgan Stanley Keeps Their Sell Rating on Evonik (0QDS)

David Symonds

Exane BNP Paribas

€22

Buy

66.67%

Upside

Initiated

07/16/25

Exane BNP Paribas Initiates a Buy Rating on Evonik (0QDS)

Andreas Heine

Stifel Nicolaus

€23

Buy

74.24%

Upside

Reiterated

03/18/25

Evonik's Strong Growth Potential and Resilience: A Buy Recommendation by Andreas Heine

Stocks with the Highest Top Analyst Consensus in the Basic Materials Sector

xxx

Find stocks in the Basic Materials sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Evonik

1 Month

xxx

Success Rate

9/15 ratings generated profit

Average Return

+0.66%

reiterated a xxx

rating 9 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +0.66% per trade.

3 Months

xxx

Success Rate

10/16 ratings generated profit

Average Return

+2.98%

reiterated a xxx

rating 10 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +2.98% per trade.

1 Year

Georgina Fraser CFAGoldman Sachs

Success Rate

29/39 ratings generated profit

Average Return

+10.64%

downgraded a sell rating 2 months ago

Copying Georgina Fraser CFA's trades and holding each position for 1 Year would result in 74.36% of your transactions generating a profit, with an average return of +10.64% per trade.

2 Years

xxx

Success Rate

28/39 ratings generated profit

Average Return

+11.81%

downgraded a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 71.79% of your transactions generating a profit, with an average return of +11.81% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0QDS Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0QDS has received 2 Buy Ratings, 14 Hold Ratings, and 4 Sell Ratings. 0QDS average Analyst price target in the past 3 months is 14.41.

Each month's total comprises the sum of three months' worth of ratings.

0QDS Financial Forecast

0QDS Earnings Forecast

Next quarter’s earnings estimate for 0QDS is >-€0.01 with a range of -€0.28 to €0.15. The previous quarter’s EPS was €0.27. 0QDS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 43.91% of the time in the same period. In the last calendar year 0QDS has Performed in-line its overall industry.

0QDS Sales Forecast

Next quarter’s sales forecast for 0QDS is €3.34B with a range of €3.24B to €3.51B. The previous quarter’s sales results were €3.39B. 0QDS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 46.88% of the time in the same period. In the last calendar year 0QDS has Performed in-line its overall industry.

0QDS Stock Forecast FAQ

What is GB:0QDS’s average 12-month price target, according to analysts?

Based on analyst ratings, Evonik’s 12-month average price target is 14.41.

What is GB:0QDS’s upside potential, based on the analysts’ average price target?

Evonik has 9.17% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Evonik a Buy, Sell or Hold?

Evonik has a consensus rating of Hold, which is based on 1 buy ratings, 7 hold ratings and 3 sell ratings.

What is Evonik’s share price target?

The average share price target for Evonik is 14.41. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €20.40 ,and the lowest forecast is €11.60. The average share price target represents 9.17% Increase from the current price of €13.2.

What do analysts say about Evonik?

Evonik’s analyst rating consensus is a Hold. This is based on the ratings of 11 Wall Streets Analysts.

How can I buy shares of Evonik?

To buy shares of GB:0QDS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Evonik (0QDS) Share Forecast & Price Target

0QDS Analyst Ratings

0QDS Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Evonik

0QDS Analyst Recommendation Trends

0QDS Financial Forecast

0QDS Earnings Forecast

0QDS Sales Forecast

0QDS Stock Forecast FAQ

Detailed List of Analyst Forecasts